ProCE Banner Activity

ACCELERATE: Phase III Study of Adjuvant Chemotherapy ± Chemoradiation in Gallbladder Cancer

Conference Coverage
Slideset

The phase III ACCELERATE trial of adjuvant chemoradiation plus chemotherapy vs chemotherapy alone showed no improvement in relapse-free survival with added chemoradiation in patients with gallbladder cancer.

Released: February 04, 2025

Expiration: August 03, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Exelixis, Inc., and Novartis Pharmaceuticals Corporation.

Boehringer Ingelheim Pharmaceuticals, Inc.

Exelixis, Inc.

Novartis Pharmaceuticals Corporation